The Discounted Cash Flow (DCF) valuation of Qianjiang Yongan Pharmaceutical Co Ltd (002365.SZ) is 7.01 CNY. With the latest stock price at 14.01 CNY, the upside of Qianjiang Yongan Pharmaceutical Co Ltd based on DCF is -49.9%.
Based on the latest price of 14.01 CNY and our DCF valuation, Qianjiang Yongan Pharmaceutical Co Ltd (002365.SZ) is a sell. selling 002365.SZ stocks now will result in a potential gain of 49.9%.
| Range | Selected | |
| WACC / Discount Rate | 8.3% - 10.5% | 9.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 5.45 - 10.62 | 7.01 |
| Upside | -61.1% - -24.2% | -49.9% |